Jump to start of content

ABIM Scheduled Maintenance Expand/Collapse the ABIM alert.

ABIM.org will be going through scheduled maintenance from 6 p.m. ET to 10 p.m. ET on Sat., 6/15/24. During this time, the ABIM Physician Portal will be unavailable. We apologize for any inconvenience this may cause. Thank you for your patience.

Breadcrumb trail:

Endocrinology, Diabetes, & Metabolism Approval Committees

Longitudinal Knowledge Assessment

Expand All | Collapse All

Susan L. Samson, MD, PhD, FRCPC, FACE, Chair

Dr. Samson is a board-certified endocrinologist and Chair of the Division of Endocrinology, Department of Medicine at Mayo Clinic Florida. She is cross appointed to the Department of Neurologic Surgery, specializing in pituitary disorders. She is originally from Canada and is a Fellow of the Royal College of Canada in Internal Medicine and Endocrinology.

She has served the American Program Directors of Endocrinology and Metabolism (Council Member and Secretary/Treasurer), Accreditation Council of Graduate Medical Education (Taskforce Member, Endocrinology, Diabetes and Metabolism Fellowship Milestones 2.0), and the American Board of Internal Medicine (Self-Assessment Committee, Item Writing Task force, and now Longitudinal Assessment Approval Committee). Dr. Samson is on the Executive Committee of the American Association of Clinical Endocrinology.

 She was the Medical Director of the Baylor St. Luke's Pituitary Center and the Endocrinology Fellowship Director, having trained more than 60 endocrinology fellows during her time as Associate Program Director and Program Director. She was awarded the Fulbright and Jaworski L.L.P. Faculty Excellence Award for Teaching and Evaluation, the Rising Star Award, and Woman of Excellence Award during her time at Baylor College of Medicine.

Dr. Samson earned her medical degree at Queen’s University, Kingston, Ontario and completed her residency at the University of Calgary, Alberta, Canada. She received her fellowship training in endocrinology, diabetes and metabolism at Baylor College of Medicine in Houston, Texas.

As of August 2022, Dr. Samson reported the following external relationships:

Industry-supported online continuing medical education supported by the following, with honoraria:

  • The Endocrine Society, Planning Committee, educational grant from Amryt Pharma for a CME-certified virtual series on treatment of acromegaly

Dr. Samson serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The American Association of Clinical Endocrinology, Board of Directors, Treasurer and Interim President-Elect, without compensation

Stephanie A. Fish, MD

Dr. Fish is a board certified endocrinologist. She is an associate member in the Endocrine Division at the Memorial Sloan Kettering Cancer Center and an associate clinical professor of Medicine at Weill Cornell School of Medicine. As a clinician, Dr. Fish focuses on the care of patients with thyroid disease, specifically thyroid cancer. She is also the Associate Program Director of the Combined Endocrine Fellowship Program at Memorial Sloan Kettering Cancer Center and Weill Cornell School of Medicine.

After completing her training, Dr. Fish joined the faculty in the Division of Endocrinology, Diabetes and Metabolism at the University of Pennsylvania. She was an instructor of medicine from 2002 to 2004 and an assistant professor of medicine from 2004 to 2010.

Dr. Fish is an active member of the Endocrine Society and the American Thyroid Association (ATA). She has been the co-Director of the Fellow’s Program during the annual ATA meeting since 2005. She is Clinical Chair of the Program Committee for the annual ATA meeting. Dr. Fish is also a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Self-Assessment Committee. She has also taught innumerable thyroid ultrasound courses to endocrinologists and fellows across the country.

Dr. Fish completed her undergraduate degree at the University of Pennsylvania, and she received her medical degree from New York University School of Medicine. She returned to the University of Pennsylvania School of Medicine for residency training in internal medicine and fellowship training in endocrinology.

As of July 2022, Dr. Fish reported the following external relationships:

Dr. Fish serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Thyroid Association, Patient Affairs Committee, Member, without compensation
  • The Endocrine Society, Meeting Planning Committee, Member, without compensation

Sky Graybill, MD

Dr. Graybill is Associate Professor of Medicine at Uniformed Services University, Endocrinology Chief at Brooke Military Medical Center, Army Endocrine Consultant for the Office to the Surgeon General, Champion for the VA/DoD guidelines on obesity management, and co-Chair for the Endocrine Society's Fellow Training Series. Research interests include thyroid dysfunction, endocrine neoplasia, hypogonadism, diabetes, and metabolic bone disease.

Dr. Graybill received her undergraduate degree from The Pennsylvania State University, State College, Pennsylvania and her medical degree from Temple University School of Medicine, Philadelphia, Pennsylvania. She completed her residency in internal medicine at Walter Reed Army Medical Center, Washington, DC and her fellowship in endocrinology at Walter Reed National Military Medical Center, Bethesda, Maryland.

As of June 2023, Dr. Graybill reported the following ongoing external relationships:

Dr. Graybill serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Endocrine Society, Education Committee Member, without compensation

Ugis Gruntmanis, MD

Dr. Gruntmanis is currently a Professor of Medicine at Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. He is Board certified in Endocrinology, Diabetes & Metabolism and is currently participating in Maintenance of Certification.

Dr. Gruntmanis practices at Dartmouth-Hitchcock Medical Center where he is Director of Bone Health and Osteoporosis Program. His passionate about graduate and postgraduate teaching and is one of the On-Doctoring, longitudinal small group mentors for first year medical students at Geisel.

He was the Associate Program Director of the Internal Medicine Residency program at University of Texas Southwestern Medical Center until 2018 and Section Chief, of Endocrinology at Dallas VA Medical Center until 2014. His area of research interest is osteoporosis, more specifically male osteoporosis and Value Care in patients post minimal trauma fractures.

Dr. Gruntmanis is a member of several professional organizations such as the Endocrine Society, National Osteoporosis Foundation and President of Latvian Medical and Dental Association. He was member of Item-Writing Task Force and now on Endocrinology, Diabetes and Metabolism Approval Committee.

He received his medical degree from Riga Stradins University, in Riga, Latvia. Dr. Gruntmanis then did his internal medicine residency at Yale and University of Rochester, New York. He completed his endocrinology fellowship at Cedars-Sinai Medical Center/UCLA, Los Angeles, California.

As of July 2022, Dr. Gruntmanis reported the following external relationships:

Dr. Gruntmanis serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Latvian Medical and Dental Association, President, without compensation

Asra Kermani, MD

Dr. Kermani is a board certified endocrinologist and Associate Professor at the University of Texas Southwestern Medical Center. She maintains an active endocrinology practice and teaches fellows and residents at Parkland Health in Dallas. Dr. Kermani also serves as Medical Director for Diabetes at Southwestern Health Resources, a large accountable care organization.

At Southwestern Health Resources, Dr. Kermani has been active in creating a predictive model for diabetes progression using artificial intelligence. She is involved in working with primary care physicians (PCP) and endocrinologists to help with practicing standards of care in the care of patients with diabetes as well as integrating care management, dietician and pharmacy services into PCP practices.

Dr. Kermani is currently a member of the Community Engagement Committee, Kidney Precision Medicine Project (KPMP), a prospective cohort study to help create a tissue atlas from renal biopsies and other specimens on patients with chronic kidney disease and acute kidney injury to better understand mechanisms of disease and develop precision treatment strategies. As a member of the Community Engagement Committee, she edited the Clinician Primer to help educate primary care physicians about KPMP and edited the Adverse Effects Communication Plan and Reporting of Results Plan. She works closely to represent the patient population that is participating in KPMP and helping clinicians better understand the rationale for the study.

Dr. Kermani has served as a subject matter expert in endocrinology for the American College of Physicians (ACP). She was involved in the ACP Care Coordination Workgroup, created and sponsored by the ACP Council of Subspecialty Societies, in January 2019. 

Dr. Kermani received her medical degree from the Medical College of Aga Khan University. She completed her internal medicine residency and fellowship in endocrinology at the University of Texas Health Science Center at Houston. 

As of Dec 2020, Dr. Kermani reported no ongoing external relationships.

Graham McMahon, MD, MMSc

Dr. McMahon is the President and Chief Executive Officer of the Accreditation Council for Continuing Medical Education (ACCME®), which leverages the power of education to drive quality in the medical profession and in healthcare. Dr. McMahon leads initiatives to accelerate learning, change, and growth, enabling clinicians and teams in practice to improve care for patients, families, and communities. In addition to his role at the ACCME, Dr. McMahon serves as Adjunct Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, teaches medical students and fellows, and continues to care for patients with endocrine disorders at Howard Brown Health.

A medical educator, researcher, and endocrinologist, Dr. McMahon joined the ACCME in April 2015 from Harvard Medical School, where he served as Associate Dean for Continuing Education and Associate Professor of Medicine. He taught extensively at Harvard Medical School and at Brigham and Women's Hospital in Boston, served as Editor for Medical Education at the New England Journal of Medicine (NEJM), and as Executive Editor for the NEJM Knowledge+ program. He served as an endocrinologist in practice and as the Fellowship Program Director in the Division of Endocrinology, Diabetes and Hypertension at the Brigham & Women's Hospital, and is a recipient of several major grants, and national awards for excellence in diabetes care innovation, systems change, and medical education.

A native of Dublin, Ireland, Dr. McMahon earned his medical degree from the Royal College of Surgeons in Ireland; he also received a doctoral degree in medical education from the National University of Ireland. He is board certified in internal medicine as well as endocrinology, diabetes, and metabolism. He earned a Master of Medical Science in Clinical Research from Harvard Medical School.

As of May 2023, Dr. McMahon reported the following external relationships:

  • The Accreditation Council for Continuing Medical Education, President and Chief Executive Officer

Traditional, 10-Year MOC Exam

Expand All | Collapse All

Shehzad S. Basaria, MD, Chair

Shehzad S. Basaria, MDDr. Basaria is a Reproductive Endocrinologist and the Medical Director of the Section of Men's Health, Aging and Metabolism at the Brigham and Women's Hospital, Harvard Medical School. He is board certified in Endocrinology, Diabetes, and Metabolism.

Dr. Basaria is a clinical investigator in the field of male reproductive endocrinology. His research interests include the role of testosterone in pain perception, age-related androgen deficiency and cardiometabolic consequences of androgen deprivation therapy in men with prostate cancer. Dr. Basaria also provides clinical care to patients with male reproductive disorders. Additionally, he is a mentor to junior faculty and endocrine fellows pursuing their careers in reproductive endocrinology.

Dr. Basaria is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board Exam Committee. He is the Associate Editor of the Journal of Gerontology Medical Sciences, and also serves on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and Endocrine Practice. Previously, Dr. Basaria led the section on Male Reproduction on the Self-Assessment Committee of the Endocrine Society. He was also previously involved in developing the Endocrine Society's Male Androgen Deficiency Performance Improvement Module, which practicing endocrinologists utilize towards their Maintenance of Certification. Dr. Basaria serves as a member of the National Institute of Child Health and Development's Special Emphasis Panel on Male Contraception.

Dr. Basaria received his medical degree from the Aga Khan University in Karachi, Pakistan. He completed house staff training at the University of Texas Health Science Center at Houston and his endocrine fellowship at the Johns Hopkins University School of Medicine.

As of May 2023, Dr. Basaria reported no external relationships.

Cyrus V. Desouza, MD

Cyrus V. Desouza, MD Dr. Desouza is currently a Professor of Medicine and the Chief of Endocrinology at the University of Nebraska Medical Center in Omaha, Nebraska. He is board certified in Endocrinology, Diabetes & Metabolism and is currently participating in Maintenance of Certification. Dr. Desouza practices at the University of Nebraska Medical Center as well as the Omaha VA. He is also the Director of the Diabetes & Obesity Program at the Omaha VA.

He was the Associate Program Director of the Endocrinology fellowship and then the Program Director until 2011. His area of research interest is diabetes and its complications and more specifically cardiovascular complications and the effect of newer generation of diabetes medications on cardiovascular disease outcomes. He does both basic research and clinical trials.

Dr. Desouza is a member of several professional organizations such as the Endocrine Society and American Diabetes Association and has served on several national committees. He is also a reviewer for Department of Defense and National Institute of Health study sections and has published over 80 articles in multiple journals.

He received his medical degree from St. John's Medical College in Bangalore, India. Dr. Desouza then did his internal medicine residency at St. Barnabas Hospital in New York. He completed his endocrinology fellowship at Tulane University Medical Center, New Orleans, Louisiana.

As of June 2023, Dr. Desouza reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to the University of Nebraska Medical Center from the following companies for trials relating to cardiovascular disease outcomes:

  • Eli Lilly and Company
  • Novartis
  • Novo Nordisk

Attendance at investigators’ meetings, with compensation for travel expenses from the following company:

  • Novo Nordisk

Service on a research-related expert panel for the following companies, with honoraria:

  • AstraZeneca
  • Novo Nordisk

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:

  • Asashi
  • Bayer

Teaching in satellite symposia funded by the following company, with honoraria:

  • Asashi

Dr. DeSouza serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The Endocrine Society, Advocacy Committee, without compensation

Funding from nonprofit health care-related organizations for salary support, staff and expenses, paid to the University of Nebraska Medical Center, from the following companies:

  • The National Institute of Diabetes and Digestive and Kidney Diseases, receiving funding for salary support for the study “Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study”
  • Veterans Affairs, receiving funding for salary support, staff and expenses

Dr. DeSouza also reported receiving reimbursement for travel expenses for serving on a Veterans Affairs safety and monitoring board.

Matthew T. Drake, MD, PhD

Matthew T. Drake, MD, PhDDr. Drake is a Consultant in the Division of Endocrinology, Department of Medicine, and Associate Professor of Medicine at Mayo Clinic in Rochester, Minnesota. He is Board Certified in Endocrinology, Diabetes, and Metabolism.

Dr. Drake has received numerous awards, including the American Society for Bone and Mineral Research Young Investigator Award and the Mayo Clinic Department of Medicine New Investigator Award. He currently serves as Chair of the Mayo Clinic Metabolic Bone Disease Core Group. He also serves on the editorial boards of the Journal of Bone and Mineral Research; Bone; the Journal of Clinical Endocrinology and Metabolism; and Mayo Clinic Proceedings, and on the Scientific Advisory Board for the Soft Bones Foundation.

In his clinical practice, Dr. Drake is involved in providing care to patients with a variety of metabolic bone diseases. In addition, he performs translational research with areas of interest including understanding the mechanisms underlying age-associated bone loss and diabetes-associated skeletal fragility, as well as the basis by which monoclonal gammopathies induce bone loss and fractures.

Dr. Drake received his undergraduate degree in biology from Harvard College and completed his medical and doctoral degrees at Washington University in St. Louis, Missouri. His clinical training in internal medicine was completed at Duke University Medical Center in Durham, North Carolina. Dr. Drake completed his endocrinology fellowship training at the Mayo Clinic, where he subsequently joined the staff in 2007.

As of July 2022, Dr. Drake reported the following external relationships:

Funding for clinical trial expenses and staff, paid to the Mayo Clinic, from the following companies:

  • Ipsen, for potential treatment for fibrodysplasia ossificans progressiva
  • Regeneron, for potential treatment for fibrodysplasia ossificans progressiva

Work as an author or editor for the following companies, with compensation as listed:

  • UpToDate®, receiving compensation for co-authorship for two chapters on osteomalacia
  • Wiley-Blackwell, deputy editor board for JBMR Plus®

Dr. Drake serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Society for Bone and Mineral Research, Professional Practice Committee, Chair, without compensation
  • The Fibrous Dysplasia Foundation, Scientific Advisory Board, Member, without compensation
  • The Food & Drug Administration, Bone, Reproductive, & Urologic Drugs Advisory Committee, Member, receiving honoraria and reimbursement for travel expenses
  • The National Institutes of Health, study section member, receiving honoraria and reimbursement for travel expenses
  • The Soft Bones Foundation, Scientific Advisory Board, Member, without compensation

Pamela U. Freda, MD

Pamela U. Freda, MDDr. Freda is Professor of Medicine at Columbia University Irving Medical Center in New York. Dr. Freda is Clinical Director of Neuroendocrine Unit and co-director of the Pituitary Center at Columbia University Irving Medical Center. She is an Assistant Attending in Medicine at New York Presbyterian Hospital. Dr. Freda is board certified in Endocrinology, Diabetes and Metabolism (recertified 2005 and 2015), was board certified in Internal Medicine (recertified 2001) and is an active participant in the Maintenance of Certification program.

She joined the faculty of the Division of Endocrinology, Department of Medicine, Columbia University of Physicians & Surgeons in 1994 and has remained on this faculty since this time. She conducts clinical research on pituitary diseases, teaches students, residents and fellows and practices Endocrinology with a focus on care of patients with pituitary tumors.

Dr. Freda served as Endocrine Society Self-Assessment Committee Member from 2010 – 2015, the Board of Directors of The Pituitary Society from 2010-2014 and as Chair of the Endocrine Society Clinical Guidelines Task Force on Pituitary Incidentaloma in 2011. At Columbia University Medical Center, she has served on the GCRC Scientific Advisory Committee and currently serves as a Consultant for the Institutional Review Board and on the Clinical Trials Office Scientific Advisory Committee. Dr. Freda became a member of the Academy of Clinical Excellence, Columbia University Medical Center in 2016.

She received her undergraduate degree in history and science from Harvard College and her medical degree from Columbia College of Physicians and Surgeons. She completed house staff training in internal medicine at The Presbyterian Hospital and her endocrinology fellowship at Columbia College of Physicians and Surgeons and The Presbyterian Hospital in New York.

As of August 2022, Dr. Freda reported no external relationships.

Jennifer Green, MD

Dr. Green is a professor of medicine in endocrinology, metabolism, and nutrition at Duke University and a faculty member of the Duke Clinical Research Institute. She received her doctorate from University of Virginia and completed her residency at the University of North Carolina at Chapel Hill.

Dr. Green served as chief of the Endocrinology section at the Durham VA Medical Center from 2003-2017. Her clinical and research interests focus on strategies to predict, prevent, and treat diabetes mellitus and its complications.

As of August 2022, Dr. Green reported the following external relationships.

Funding for salary support, paid to Duke University, from the following companies:

  • Boehringer Ingelheim, for serving as a principal investigator for a trial and a coinvestigator for an implementation study
  • Merck, for a trial evaluating cardiovascular outcomes with sitagliptin data publications
  • Roche, for diabetes test bed development

Service on data and safety monitoring boards for the following company, with no compensation to date:

  • Valo

Consulting on the design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with honoraria:

  • Anji/LabCorp
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • ICON/Vertex
  • Novo Nordisk
  • Pfizer
  • Sanofi

Dr. Green serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Diabetes Association, Professional Practice Committee, Member; American Diabetes-European Association for the Study of Diabetes Writing Group, Member, without compensation
  • The Metabolic Institute of America, for presentations at a continuing medical education conference, receiving honoraria

Dr. Green also reported giving multiple continuing medical education presentations with scientific sessions.

Savitha Subramanian, MD

Dr. Savitha Subramanian is Associate Professor at the University of Washington (UW) Department of Medicine, Division of Metabolism, Endocrinology and Nutrition. She is board certified in Endocrinology and Metabolism.

Dr. Subramanian is the Medical Director of the UW Lipid Clinic with special expertise in managing individuals with genetic lipid disorders, partial lipodystrophy and complex diabetes. Her research has focused on studying the molecular mechanisms driving inflammation in obese adipose tissue, liver and atherosclerosis. Her other clinical interest includes diabetes management in primary care, having done extensive work as part of a collaborative care model for diabetes working with primary care physicians in the greater Seattle area. She is the physician lead for diabetes population health management for UW Medicine and has developed standardization pathways for outpatient diabetes management for primary care.

Locally, Dr. Subramanian is also involved in many teaching activities for trainees and clinicians. She is the co-chair of the popular Diabetes and Endocrine Update for Primary Care CME courses for the University of Washington. She is a recent past member of the Endocrine Self-Assessment Program workgroup and is currently part of the Lipid Management Guideline task force of the Endocrine Society.

She obtained her medical degree from Stanley Medical College in Chennai, India, and completed an internal medical residency at the University of Illinois College of Medicine, Urbana Illinois. She did an endocrinology fellowship at Washington University in St. Louis, Missouri, and a research fellowship at the University of Washington in Seattle, Washington.

As of June 2023, Dr. Subramanian reported the following ongoing external relationships:

Dr. Subramanian serves on the Abbott Primary Care Diabetes Advisory Board, receiving honoraria.

Dr. Subramanian serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The National Lipid Association, Pacific Lipid Association, Member at Large, without compensation